Cargando…

Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence

Alopecia is a clinical condition related to hair loss that can significantly affect both male and female adults’ quality of life. Despite the high market demand, only few drugs are currently approved for alopecia treatment. Topical formulations still bring drawbacks, such as scalp irritation with fr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso, Camila O, Tolentino, Seila, Gratieri, Tais, Cunha-Filho, Marcilio, Lopez, Renata F V, Gelfuso, Guilherme M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126704/
https://www.ncbi.nlm.nih.gov/pubmed/34012282
http://dx.doi.org/10.2147/CCID.S284435
_version_ 1783693817708281856
author Cardoso, Camila O
Tolentino, Seila
Gratieri, Tais
Cunha-Filho, Marcilio
Lopez, Renata F V
Gelfuso, Guilherme M
author_facet Cardoso, Camila O
Tolentino, Seila
Gratieri, Tais
Cunha-Filho, Marcilio
Lopez, Renata F V
Gelfuso, Guilherme M
author_sort Cardoso, Camila O
collection PubMed
description Alopecia is a clinical condition related to hair loss that can significantly affect both male and female adults’ quality of life. Despite the high market demand, only few drugs are currently approved for alopecia treatment. Topical formulations still bring drawbacks, such as scalp irritation with frequent use, and low drug absorption to the site of action, which limits the efficacy. The most recent research points out that different formulation technology could circumvent the aforementioned flaws. Such technology includes incorporation of drugs in rigid or deformable nanoparticles, strategies involving physical, energetical and mechanical techniques, such as iontophoresis, sonophoresis, microneedling, and the use of solid effervescent granules to be hydrated at the moment of application in the scalp. In this paper, the progress of current research on topical formulations dedicated to the treatment of alopecia is reviewed and discussed.
format Online
Article
Text
id pubmed-8126704
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-81267042021-05-18 Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence Cardoso, Camila O Tolentino, Seila Gratieri, Tais Cunha-Filho, Marcilio Lopez, Renata F V Gelfuso, Guilherme M Clin Cosmet Investig Dermatol Review Alopecia is a clinical condition related to hair loss that can significantly affect both male and female adults’ quality of life. Despite the high market demand, only few drugs are currently approved for alopecia treatment. Topical formulations still bring drawbacks, such as scalp irritation with frequent use, and low drug absorption to the site of action, which limits the efficacy. The most recent research points out that different formulation technology could circumvent the aforementioned flaws. Such technology includes incorporation of drugs in rigid or deformable nanoparticles, strategies involving physical, energetical and mechanical techniques, such as iontophoresis, sonophoresis, microneedling, and the use of solid effervescent granules to be hydrated at the moment of application in the scalp. In this paper, the progress of current research on topical formulations dedicated to the treatment of alopecia is reviewed and discussed. Dove 2021-05-12 /pmc/articles/PMC8126704/ /pubmed/34012282 http://dx.doi.org/10.2147/CCID.S284435 Text en © 2021 Cardoso et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Cardoso, Camila O
Tolentino, Seila
Gratieri, Tais
Cunha-Filho, Marcilio
Lopez, Renata F V
Gelfuso, Guilherme M
Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
title Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
title_full Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
title_fullStr Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
title_full_unstemmed Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
title_short Topical Treatment for Scarring and Non-Scarring Alopecia: An Overview of the Current Evidence
title_sort topical treatment for scarring and non-scarring alopecia: an overview of the current evidence
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8126704/
https://www.ncbi.nlm.nih.gov/pubmed/34012282
http://dx.doi.org/10.2147/CCID.S284435
work_keys_str_mv AT cardosocamilao topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence
AT tolentinoseila topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence
AT gratieritais topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence
AT cunhafilhomarcilio topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence
AT lopezrenatafv topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence
AT gelfusoguilhermem topicaltreatmentforscarringandnonscarringalopeciaanoverviewofthecurrentevidence